Cargando…
Osteocalcin Alleviates Nonalcoholic Fatty Liver Disease in Mice through GPRC6A
Osteocalcin is a bone-derived hormone that plays an important role in the crosstalk between bone and energy metabolism. Previous studies have found that treatment with uncarboxylated osteocalcin can protect mice from high-fat diet-induced nonalcoholic fatty liver disease (NAFLD). However, the potent...
Autores principales: | Zhang, Mingliang, Nie, Xiaomin, Yuan, Yeqing, Wang, Yansu, Ma, Xiaojing, Yin, Jun, Bao, Yuqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834799/ https://www.ncbi.nlm.nih.gov/pubmed/33531899 http://dx.doi.org/10.1155/2021/9178616 |
Ejemplares similares
-
Undercarboxylated osteocalcin inhibits the early differentiation of osteoclast mediated by Gprc6a
por: Wang, Hailong, et al.
Publicado: (2021) -
Explaining Divergent Observations Regarding Osteocalcin/GPRC6A Endocrine Signaling
por: Pi, Min, et al.
Publicado: (2021) -
Adiponectin receptor 1 resists the decline of serum osteocalcin and GPRC6A expression in ovariectomized mice
por: Lin, Yuan-Yu, et al.
Publicado: (2017) -
Osteocalcin-GPRC6A: An update of its clinical and biological multi-organic interactions
por: Diaz-Franco, Martha Cristina, et al.
Publicado: (2019) -
Osteocalcin Promotes β-Cell Proliferation During Development and Adulthood Through Gprc6a
por: Wei, Jianwen, et al.
Publicado: (2014)